Biosenta Announces Critical Improvements to Intellectual Property Ownership

Biosenta Inc. (CSE:ZRO) - 

Highlights



--  Corporate Advisor Bassett Financial negotiates Intellectual Property
    Consolidation 
    --  Intellectual Property to be owned by Biosenta, not licensed 
    --  Royalties on Sales payable to Insiders is Eliminated 
    --  $625,000 of debt payable to Directors is Eliminated 
    --  Reduction of Shares Issued for IP by 4.8 million Common Shares



BIOSENTA INC. ("Biosenta" or the "Company") is pleased to announce that, through
the efforts of its Corporate Financial Advisor, Bassett Financial Corporation
("BFC"), the Company has negotiated a complete change in how the Intellectual
Property used and being developed by Biosenta, is owned and managed.


Under the direction of BFC, the parties have agreed to suspend the Amended
License Agreement and enter into a new Agreement that includes the following:




--  All patents, rights and know-how related to patent numbers WO
    2013/053064 and WO 2014/036659 are assigned to Biosenta Inc. with the
    provision that such assignment can be revoked only if sufficient funding
    for the Parry Sound facility (expected to be approximately $5 million)
    has not been raised prior to December 31, 2015. 
--  Marcus Martin will be employed by Biosenta and will continue to be
    involved in a new project team that will also include BFC that will work
    diligently to complete the development and construction of the Parry
    Sound facility on an organized and fast- track basis. 
--  A net amount of 4,800,000 shares owned and in escrow pursuant to the
    Amended License will be immediately cancelled. 
--  The Royalties to be paid under the Amended License are terminated. 
--  The Amended License is terminated and Biosenta will now own the
    patents. 



"This is a huge win for all of the shareholders of Biosenta," says Bassett
Financial CEO Matthew Bassett. "While not part of our original mandate, we
recognized from our earliest days after we became involved with Biosenta that
not having all parties equally aligned was a long term impediment for this
Company. Among the several other improvements we have helped the Company
achieve, consolidating the Intellectual Property ownership into the Company was
the biggest change that needed to be made and we are proud to have led this
change on behalf of the company and more importantly its shareholders."


"We are pleased that this important step has been completed and that we can
bring value to all shareholders," said Biosenta CEO Chris Bilz. "This is an
important chapter in the development of this company and we are looking forward
to a renewed, and refocused development effort being deployed immediately to get
the Parry Sound facility completed and operational."


About Biosenta Inc.

Biosenta Inc.'s line of retail anti-microbial products will effectively kill
mould, bacteria and fungi on contact and prevent re-growth. These products
address the demand created by the mounting health and environmental concerns.
Mould can affect the immune system, nervous system, liver, kidneys, blood and
can cause brain damage.


On behalf of the Board of Directors of Biosenta Inc.

Chris Bilz, CEO & President

The CSE has in no way passed upon the merits of the proposed transaction and has
neither approved nor disapproved of the contents of this press release. Neither
the CSE nor its Regulation Services Provider (as such term is defined in the
policies of the CSE) accepts responsibility for the adequacy or accuracy of this
release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Biosenta Inc.
Chris Bilz
CEO & President
[phone]


Investor Cubed Inc.
Neil Simon
Investor Relations
647-258-3311
888-258-3323
[e-mail]